CRISPR, Gene Therapies, and Cure Pricing Conundrums
Motley Fool Money
The Price of Cures: Navigating Gene Therapy Economics
This chapter explores the challenging landscape of pricing gene therapies, contrasting them with traditional drugs while discussing market reactions and investor concerns. Key case studies illustrate the complexities of generating affordable yet effective treatments, alongside the regulatory hurdles innovators face in the evolving therapeutic field.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
